FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626683721> ?p ?o ?g. }

• W2626683721 endingPage "289" @default.
• W2626683721 startingPage "280" @default.
• W2626683721 abstract "The scale-up of HIV self-testing (HIVST) in Africa is recommended, but little is known about how this novel approach influences economic outcomes following subsequent antiretroviral treatment (ART) compared with established facility-based HIV testing and counseling (HTC) approaches.HIV clinics in Blantyre, Malawi.Consecutive HIV-positive participants, diagnosed by HIVST or facility-based HTC as part of a community cluster-randomized trial (ISRCTN02004005), were followed from initial assessment for ART until 1-year postinitiation. Healthcare resource use was prospectively measured, and primary costing studies undertaken to estimate total health provider costs. Participants were interviewed to establish direct nonmedical and indirect costs over the first year of ART. Costs were adjusted to 2014 US$ and INT$. Health-related quality of life was measured using the EuroQol EQ-5D at each clinic visit. Multivariable analyses estimated predictors of economic outcomes.Of 325 participants attending HIV clinics for assessment for ART, 265 were identified through facility-based HTC, and 60 through HIVST; 168/265 (69.2%) and 36/60 (60.0%), respectively, met national ART eligibility criteria and initiated treatment. The mean total health provider assessment costs for ART initiation were US$22.79 (SE: 0.56) and US$19.92 (SE: 0.77) for facility-based HTC and HIVST participants, respectively, and was US$2.87 (bootstrap 95% CI: US$1.01 to US$4.73) lower for the HIVST group. The mean total health provider costs for the first year of ART were US$168.65 (SE: 2.02) and US$164.66 (SE: 4.21) for facility-based HTC and HIVST participants, respectively, and comparable between the 2 groups (bootstrap 95% CI: -US$12.38 to US$4.39). EQ-5D utility scores immediately before and one year after ART initiation were comparable between the 2 groups. EQ-5D utility scores 1 year after ART initiation had increased by 0.129 (SE: 0.011) and 0.139 (SE: 0.027) for facility-based HTC and HIVST participants, respectively.Once HIV self-testers are linked into HIV services, their economic outcomes are comparable to those linking to services after facility-based HTC." @default.
• W2626683721 created "2017-06-23" @default.
• W2626683721 creator A5033232150 @default.
• W2626683721 creator A5036267935 @default.
• W2626683721 creator A5086633752 @default.
• W2626683721 creator A5087136833 @default.
• W2626683721 creator A5087777785 @default.
• W2626683721 creator A5089167457 @default.
• W2626683721 creator A5089796204 @default.
• W2626683721 date "2017-07-01" @default.
• W2626683721 modified "2023-10-16" @default.
• W2626683721 title "Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial" @default.
• W2626683721 cites W1553864609 @default.
• W2626683721 cites W1811824508 @default.
• W2626683721 cites W1968106809 @default.
• W2626683721 cites W1968805308 @default.
• W2626683721 cites W1969678359 @default.
• W2626683721 cites W1971883474 @default.
• W2626683721 cites W1983018462 @default.
• W2626683721 cites W1984780633 @default.
• W2626683721 cites W1987750223 @default.
• W2626683721 cites W1994222210 @default.
• W2626683721 cites W1996146145 @default.
• W2626683721 cites W2021402729 @default.
• W2626683721 cites W2022085507 @default.
• W2626683721 cites W2035304784 @default.
• W2626683721 cites W2089373498 @default.
• W2626683721 cites W2107627025 @default.
• W2626683721 cites W2115253919 @default.
• W2626683721 cites W2124376332 @default.
• W2626683721 cites W2132241786 @default.
• W2626683721 cites W2134843796 @default.
• W2626683721 cites W2135174968 @default.
• W2626683721 cites W2135206837 @default.
• W2626683721 cites W2139255721 @default.
• W2626683721 cites W2146829799 @default.
• W2626683721 cites W2150560731 @default.
• W2626683721 cites W2155099774 @default.
• W2626683721 cites W2287489474 @default.
• W2626683721 cites W2473786944 @default.
• W2626683721 cites W3122896559 @default.
• W2626683721 doi "https://doi.org/10.1097/qai.0000000000001373" @default.
• W2626683721 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5662151" @default.
• W2626683721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28617733" @default.
• W2626683721 hasPublicationYear "2017" @default.
• W2626683721 type Work @default.
• W2626683721 sameAs 2626683721 @default.
• W2626683721 citedByCount "10" @default.
• W2626683721 countsByYear W26266837212017 @default.
• W2626683721 countsByYear W26266837212018 @default.
• W2626683721 countsByYear W26266837212019 @default.
• W2626683721 countsByYear W26266837212020 @default.
• W2626683721 countsByYear W26266837212022 @default.
• W2626683721 countsByYear W26266837212023 @default.
• W2626683721 crossrefType "journal-article" @default.
• W2626683721 hasAuthorship W2626683721A5033232150 @default.
• W2626683721 hasAuthorship W2626683721A5036267935 @default.
• W2626683721 hasAuthorship W2626683721A5086633752 @default.
• W2626683721 hasAuthorship W2626683721A5087136833 @default.
• W2626683721 hasAuthorship W2626683721A5087777785 @default.
• W2626683721 hasAuthorship W2626683721A5089167457 @default.
• W2626683721 hasAuthorship W2626683721A5089796204 @default.
• W2626683721 hasBestOaLocation W26266837212 @default.
• W2626683721 hasConcept C126322002 @default.
• W2626683721 hasConcept C144133560 @default.
• W2626683721 hasConcept C159110408 @default.
• W2626683721 hasConcept C160735492 @default.
• W2626683721 hasConcept C162324750 @default.
• W2626683721 hasConcept C162853370 @default.
• W2626683721 hasConcept C164624739 @default.
• W2626683721 hasConcept C164866538 @default.
• W2626683721 hasConcept C168563851 @default.
• W2626683721 hasConcept C176400912 @default.
• W2626683721 hasConcept C199360897 @default.
• W2626683721 hasConcept C2779951463 @default.
• W2626683721 hasConcept C3013748606 @default.
• W2626683721 hasConcept C41008148 @default.
• W2626683721 hasConcept C50522688 @default.
• W2626683721 hasConcept C512399662 @default.
• W2626683721 hasConcept C71924100 @default.
• W2626683721 hasConceptScore W2626683721C126322002 @default.
• W2626683721 hasConceptScore W2626683721C144133560 @default.
• W2626683721 hasConceptScore W2626683721C159110408 @default.
• W2626683721 hasConceptScore W2626683721C160735492 @default.
• W2626683721 hasConceptScore W2626683721C162324750 @default.
• W2626683721 hasConceptScore W2626683721C162853370 @default.
• W2626683721 hasConceptScore W2626683721C164624739 @default.
• W2626683721 hasConceptScore W2626683721C164866538 @default.
• W2626683721 hasConceptScore W2626683721C168563851 @default.
• W2626683721 hasConceptScore W2626683721C176400912 @default.
• W2626683721 hasConceptScore W2626683721C199360897 @default.
• W2626683721 hasConceptScore W2626683721C2779951463 @default.
• W2626683721 hasConceptScore W2626683721C3013748606 @default.
• W2626683721 hasConceptScore W2626683721C41008148 @default.
• W2626683721 hasConceptScore W2626683721C50522688 @default.
• W2626683721 hasConceptScore W2626683721C512399662 @default.
• W2626683721 hasConceptScore W2626683721C71924100 @default.
• W2626683721 hasIssue "3" @default.

• next